key: cord-0903388-r7o8l6jk
authors: Kayikcioglu, Meral; Tokgozoglu, Lale; Tuncel, Ozlem Kuman; Pirildar, Sebnem; Can, Levent
title: Negative impact of COVID-19 pandemic on the lifestyle and management of patients with Homozygous Familial Hypercholesterolemia
date: 2020-09-15
journal: J Clin Lipidol
DOI: 10.1016/j.jacl.2020.09.002
sha: 6228592d6d0f0b422de738d0b807f905b66ef4cd
doc_id: 903388
cord_uid: r7o8l6jk

[Figure: see text]

the community and the national health systems. [1] [2] The irrepressible prioritization of the treatment of COVID-19 has diverted all resources to the care of this enormously increasing patient population. [1] [2] However, the pandemic also had a negative impact on non-infected patients with chronic and rare diseases. 1 Severe restriction of daily life, including lockdown, to prevent the spread of the COVID-19, affected the management and access to treatments of patients with these disorders.

Homozygous Familial hypercholesterolemia (HoFH), is a rare chronic genetic disease with very high low-density lipoprotein cholesterol (LDL-C) levels leading to early atherosclerosis. 2-3 Aggressively reducing LDL-C levels is crucial for the survival of HoFH patients by delaying the progression of atherosclerosis and decreasing the incidence of major cardiovascular (CV) events. 2,3 Regular LDLapheresis (LA), in combination with standard lipid-lowering therapy (LLT), is the most effective means of lowering LDL-C. In addition, preventive lifestyle interventions including cessation of smoking, exercise, and a heart-healthy diet are fundamental for these patients. [2] [3] [4] Moreover, because of their lifelong risk of CV disease, at every age, HoFH patients may have an increased risk of experiencing a severe course of COVID-19, and may be augmented with the presence of atherosclerotic CV disease. 2 In vitro studies report a possible link via ACE2 receptors leading to increased corona-viral entry to host cells in case of high cholesterol levels. 5 Previous viral epidemics have shown that CV events significantly increase during these times in association with high LDL-C levels. 6 Therefore, in all aspects it is vital to continue the treatment of these patients and keep LDL levels low during the pandemic period. 2 We recently conducted a survey to investigate the effect of the COVID-19 outbreak and the ensuing quarantine measures on the heart healthy lifestyle, anxiety level, and management of HoFH 

Overall, half of the HoFH patients reported a disruption at least in one or more components of the healthy life behaviors since the emergence of the outbreak. Change in sleep or appetite was observed in more than one third of the patients. Patients reported that 35.3% experienced a change in sleep duration, 38.2% change in appetite and almost 60% of the population was trying to be more compliant with a healthy diet during the outbreak. However, dietary compliance was decreased in 15%. Physical activity was reduced in 50%, and 23.5% reported an increased level of exercise.

Almost 62% of the patients reported an increase in their anxiety level during the outbreak. The median anxiety level was 5 (min=0, max=9). Anxiety level was not associated with age, gender, J o u r n a l P r e -p r o o f history of CV disease, or duration of the disease. Having a previous psychiatric diagnosis or psychotropic drug use (almost 20%) did not have any impact on life style measures changes, anxiety level and was not associated with age.

Almost 80% of the study population perceived themselves more vulnerable to COVID-19 and its complications due to their underlying HoFH. Patients who claimed that HoFH would not lead to a worse prognosis reported lower anxiety level than the patients who perceived themselves vulnerable (p=0.016, z=-2.399, medians: 2 vs 5) and the ones who were unsure about it (p=0.044, z=-2.010; medians: 2 vs 7.5).

None of the study population had a diagnosis of COVID-19 nor the complaints associated with COVID-19. As these patients were on regular follow-up of median 6 years in a tertiary center, probably their awareness was higher than the general HoFH population Therefore, the personal protection against contracting the coronavirus was probably effective.

Most of the study population (73.5%) reported that they would not go to a hospital even if they had a severe complaint during the COVID-19 outbreak. The picture was the same for those with a history of CV disease; 67% reported that they would avoid going to a hospital even if they had a complaint like a chest pain which might be a sign of a fatal heart attack. Avoidance of seeking medical care was not associated with the anxiety level, the duration of follow-up in the center, and age. This striking finding of avoidance of seeking medical care in HoFH patients was completely due to fear of contracting coronavirus in health care services. This observation is extremely important as the study population constituted of patients with very high health literacy and highly aware patients of their own CV risk. The fear that these patients declared might be the underlying cause of the reduced and late number of admissions of acute coronary syndromes, reported during the COVID-19 breakout. 8

We observed that most of our patients were using their conventional LLT regularly during the pandemic period; only four (11.8%) patients could not receive CV medications regularly; three due to lack of social security and one due to forgetfulness. With the initiation of the pandemic, to avoid unnecessary visits to hospitals the Ministry of Health, enabled patients to access drugs for chronic diseases from pharmacies without new prescriptions for 6 months. This action was a very effective precaution to avoid interruption of pharmacotherapy in the management of chronic diseases during the pandemic.

However, access to LA which is a lifesaving therapy for patients with HoFH was significantly (table 1) .

Non-users were sleeping less, eating less, and trying to be more compliant with a healthy diet compared to users probably reflecting both a high risk perception and /or anxiety due to no access to an effective LLT modality.

Synchronously, we sent e-mails to other apheresis centers in the country (n=22) to ask the accessibility of LA during the pandemic period. Of note, we have been collaborating with these centers for a nationwide registry provided insight into the real-life management of HoFH patients undergoing LA in Turkey. 3 Information received from other centers revealed that LA was accessible in 61% of the centers. However, most of the patients (75%) were not attending their LA sessions with the fear of getting infected.

The hindered LA therapy in HoFH patients leads to a significant increase in LDL-C levels. Even in non-FH patients, high visit-to-visit variability in LDL-C levels is an independent predictor of adverse CV events. 9 Therefore, keeping LDL-C levels on target is extremely important in the management of J o u r n a l P r e -p r o o f these HoFH patients. The present study illuminated the importance of easily accessible LLT during a pandemic or any other disaster. Though LA is the most effective way of lowering LDL-C in HoFH patients, it is a hospital-based chronic treatment procedure. Therefore, effective pharmacotherapies are needed to avoid the dependence of these patients on the hospitals.

Gradual quarantine measures, economic concerns, emotional load, and the fear of contracting coronavirus are probably the explanation of the increased anxiety and disruption of heart-healthy lifestyle changes observed in our patients. The observed 50% decrease in compliance to at least one or more components of these healthy life behaviors denotes the need for increased follow-up and education. The current COVID-19 crisis with social distancing, lockdown and telecommuting markedly decreased levels of physical activity. 4 Staying at home with a sedentary life style and enormously increased screen-time decreased energy consumption meanwhile increasing the difficulty to access fresh fruit and vegetables hampering most of heart healthy eating habits. 4 All our findings denote the importance of being in contact with the patients and providing the necessary information, as optimum anxiety and high perceived risk were correlated with taking some preventive measures, meanwhile uncertainty of the risk and disbelief in media reports were associated with low adherence to the recommendations, in previous outbreaks. 10 Telemedicine should be in place for remote monitoring of these high CV risk patients to optimize risk factor control, physical activity levels, and assess diet while isolated. 4 Telemedicine will not only help the follow-up of these patients, but also will increase the adherence to CV medications. In addition, national scientific societies and more importantly patient organizations may play a key role in supporting patients by providing reliable, accurate information and advice in this time of greatest need. 2 

Predictors of Mortality for Patients with COVID-19 Pneumonia Caused by SARS-CoV-2: A Prospective Cohort Study

Daccord M; FH Europe and the International Lipid Expert Panel (ILEP). et al. Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic

A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)

Primary and Secondary Prevention of Cardiovascular Disease in the Era of the Coronavirus Pandemic

The role of high cholesterol in age-related COVID19 lethality

Seasonal Influenza Infections and Cardiovascular Disease Mortality

A Study of Inclisiran in Participants With Homozygous Familial Hypercholesterolemia (HoFH) (ORION-5)

Worrying decrease in hospital admissions for myocardial infarction during the COVID-19 pandemic

TNT Steering Committee and Investigators. Visit-to-visit low-density lipoprotein cholesterol variability and risk of cardiovascular outcomes: insights from the TNT trial

Intolerance of uncertainty, appraisals, coping, and anxiety: the case of the 2009 H1N1 pandemic

Study protocol was approved by both the Institutional Review Board (20-5T 49) and the Ministry of Health COVID-19 Scientific Research Oversight Committee.We cordially thank Prof Dr Serdar Payzin, MD for his preparing the Graphical Abstract. 

All authors made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.J o u r n a l P r e -p r o o f